Alkermes ALK8700 A302: A Phase 3 Study in Subjects with Relapsing Remitting Multiple Sclerosis to Evaluate the Tolerability of ALKS 8700 in Adults with Relapsing Remitting Multiple Sclerosis

July 26, 2018
https://clinicaltrials.gov/ct2/show/NCT03093324
Multiple Sclerosis
Principal Investigator: Mirela Cerghet, MD
Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, MS, RRMS
Accepting Participants